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A B S T R A C T
A disseminated peritoneal dialysis-related Mycobacterium abscessus infection is very rare. M. abscessus belongs to
the rapidly growing mycobacteria and can be misidentiﬁed as a diphtheroid bacterium, which in our case
delayed diagnosis and optimal treatment. Due to intrinsic resistance to most antimicrobials, therapeutic options
in M. abscessus infections are limited. Infection often leads to catheter loss. A fatal outcome, like in our case, is
not exceptional.
Introduction
Despite numerous preventive measures, exit-site infections (ESIs)
are a common problem in the peritoneal dialysis (PD) population. ESIs
usually respond well to empiric antimicrobial therapy aimed at Gram-
positive and Gram-negative bacteria. However, if no clinical improve-
ment occurs one should consider other infectious causes. On the basis of
our case, we would like to address important features and pitfalls of PD-
related Mycobacterium abscessus infections.
Case report
A 73-year-old Caucasian woman with end-stage renal disease who
had been treated with continuous ambulatory peritoneal dialysis
(CAPD) for 12 months presented on routine evaluation with local
tenderness and erythema at the exit-site of the PD catheter. Her medical
history was signiﬁcant for a right-sided nephrectomy because of
recurrent episodes of pyelonephritis due to nephrolithiasis, ischaemic
heart disease, and two caesarean sections.
On physical examination there was no purulent discharge from the
exit-site. The peritoneal ﬂuid was clear and the patient had no fever.
Patient history and physical examination revealed no further abnorm-
alities. According to protocol she was treated as an outpatient for an
exit-site infection (ESI) with oral ﬂucloxacillin. After ten days of
treatment there was no clinical improvement. As the exit-site culture
seemed to grow Corynebacterium species, therapy was switched to oral
amoxicillin-clavulanic acid. On day 15, it was reported that the isolate
was resistant to all tested antimicrobial agents including vancomycin.
Since there was still no sign of clinical improvement the infected
catheter was surgically removed on day 24 and in the same session a
new catheter was inserted in a diﬀerent abdominal region. She was
switched to hemodialysis (HD) via a tunnelled catheter. On day 29, 16S
ribosomal RNA polymerase chain reaction (16S rRNA PCR) identiﬁca-
tion performed on the presumed Corynebacterium isolate revealed 100%
homology with Mycobacterium chelonae-abscessus complex. Further
species identiﬁcation by the National Institute for Public Health and
the Environment (RIVM) revealed M. abscessus. As the PD catheter had
been replaced, no further therapeutic actions were undertaken.
Ten days after surgical PD catheter-replacement the patient pre-
sented with fever and abdominal complaints. This time the new PD exit-
site was inﬂamed. Laboratory studies showed an elevated C-reactive
protein level: 130 mg/L (ref. < 6 mg/L) and white blood cell count:
12.7 × 109/L (ref. 4.0–10.0 × 109/L). Ultrasonography showed no
evidence for abdominal or tunnel abscesses. Flucloxacillin was com-
menced intravenously and the patient was admitted to the nephrology
ward. Bacterial cultures taken from the exit-site, peripheral blood and
jugular venous catheter remained negative. Despite prolonged anti-
microbial therapy the patient had recurrent fever and chills, especially
during HD sessions. While initial blood cultures obtained on admission
and on day 5 remained negative, blood cultures obtained on day 11
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after admission ultimately revealed growth of M. abscessus. Immediate
removal of both the new PD catheter and the HD catheter was ordered.
Flucloxacillin was discontinued and switched to tigecycline and clari-
thromycin. Unfortunately, bilateral thrombosis of the jugular veins
occurred, which caused major access problems for adequate dialysis.
The patient was, therefore, transferred to a nearby academic hospital.
Broth microdilution susceptibility testing of the bloodstream isolate
revealed amikacin susceptibility, intermediate imipenem susceptibility
(minimum inhibitory concentration [MIC] 8 mg/L), inducible macro-
lide resistance and a tigecycline MIC of 0.25 mg/L [1]. Based hereupon,
clarithromycin was switched to imipenem. Additional imaging studies
showed no source of infection explaining the bacteraemia. Follow up
blood cultures remained negative. The patient unexpectedly died
because of ventricular ﬁbrillation directly after insertion of a central
venous catheter in the left subclavian vein.
Discussion
Among the rapidly growing nontuberculous mycobacteria (RGM),
Mycobacterium fortuitum, M. chelonae and M. abscessus are considered
clinically most relevant. They are ubiquitous in the environment,
including water, soil and dust, and survive nutritional deprivation
and extreme temperatures. The most common clinical manifestations
comprise skin and soft tissue infections, catheter-related infections and
pulmonary infections. RGM are infrequent causative agents of ESIs and
PD-peritonitis; M. abscessus infections are particularly rare in this
context with only eight previous reports comprising 23 cases (14
peritonitis; 9 ESIs) (Table 1) [2–9]. The vast majority of cases are
described in Asian countries. To the best of our knowledge, this is the
second case in literature of a M. abscessus bloodstream infection as a
complication of PD-related infection [3].
Predisposing factors for development of PD-related infections with
RGM include additional immunosuppressive conditions, recurrent
episodes of ESIs or peritonitis with multiple courses of broad-spectrum
antimicrobials, and underdialysis [5]. In addition, the use of topical
gentamicin cream is postulated as a risk factor in two reports [2,10].
None of these applied to our patient.
The microbiological similarities of RGM and Corynebacterium spe-
cies impose potential for misidentiﬁcation in the laboratory. This
phenomenon, which also happened in our case, has been previously
reported [11,12]. In order to diagnose RGM infection, performance of
auramine or Ziehl-Neelsen staining and mycobacterial culture are
essential. An earlier auramine or Ziehl-Neelsen staining might, in our
case, have led to earlier adequate antimicrobial therapy and possibly a
better clinical outcome.
M. abscessus is intrinsically resistant to most antimicrobials [1].
Treatment consists of combination therapy, usually with cefoxitin or
imipenem, amikacin and clarithromycin [1]. The minimum duration
and optimal regimen for treatment for PD-related RGM infection are not
known, but a prolonged course of antimicrobial treatment is recom-
mended, especially when the plan is to salvage the PD catheter [13].
There is no guideline recommending catheter removal following
diagnosis of PD-related RGM infection. High rates of catheter loss and
mortality are reported in PD-related RGM disease [3]. Extensive
comorbidities, as in our case, contribute to fatal outcomes [13].
Conclusion
We present a case with a disseminated PD-related M. abscessus
infection. To prevent delay in optimal antimicrobial treatment, RGM
infections should be considered when initial therapy does not lead to
clinical improvement.
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Table 1
Previously reported cases of peritoneal dialysis peritonitis and exit-site infections by Mycobacterium abscessus.
Article (Ref) Country or region Number of PD-peritonitis cases Number of ESI cases Number of cases with bloodstream infection
Lo et al., Perit Dial Int 2013 [2] Hong Kong 2 4 0
Renaud et al., Nephrology 2011 [3] Singapore 4 3 1
Kameyama et al., Ther Apher Dial 2007 [4] Japan 1 – 0
Ellis et al., Pediatr Nephrol 2005 [5] USA – 1 0
Tsai, Ther Apher Dial 2013 [6] Taiwan – 1 0
Yang et al., Perit Dial Int 2015 [7] Taiwan 2 – 0
Jiang et al., Int Urol Nephrol 2013 [8] Australia 3 – 0
Siddiqi et al., Saudi J Kidney Dis Transpl 2012 [9] Saudi Arabia 2 – 0
Abbreviations: PD, peritoneal dialysis; ESI, exit-site infection.
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